Title: Carcinoma Tonsil with Rib Metastasis: A Maiden Report

Authors: Dr Ashutosh Kumar, Dr Paramjeet Kaur, Dr Ashok Chauhan, Dr Anil Khurana, Dr Anbu Chandrasekaran, Dr Tarun Kumar

 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.65

Abstract

Presentation of the Case

The sixth most common cancer worldwide is Head and Neck squamous cell carcinoma (HNSCC).1 Twenty five percent of male cancers and ten percent of female cancers in India is Head and Neck squamous cell carcinoma (HNSCC).2 Due to oral consumption of tobacco in various forms, use of lime with betel nut and leaves and smoking , incidence of HNSCC is about six times higher in India as compared to western countries.3

In squamous cell carcinoma of head and neck, distant haematogenous spread is less frequent as compared to involvement cervical lymph node. Fourteen percent is incidence of distant metastasis of Head and Neck squamous cell carcinoma (HNSCC) in India.4

The oropharynx consists of the soft palate, tonsillar fossae, tongue base and the pharyngeal walls from the level of the soft palate cephalad to the level of the epiglottis caudad. Perhaps its most distinguishing anatomical characteristic is as the location for most of the Waldeyer’s lymphatic ring, including the palatine tonsils and the lingual tonsils and distant metastasis is a significant problem in patients with carcinoma of the oropharynx, occurring in approximately 15–20% off all patients over the course of the disease.5

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. 
  2. Yeole BB. Trends in incidence of head and neck cancers in India. Asian Pac J Cancer Prev 2007;8:607-12.
  3. Bhandari V, Jain RK. A retrospective study of incidence of bone metastasis in head and neck cancer. J Cancer Res Ther. 2013 Jan-Mar;9:90-3.
  4. Alavi S, Namazie A, Sercarz JA, Wang MB, Blackwell KE. Distant lymphatic metastasis from head and neck cancer. Ann Otol Rhinol Laryngol 1999;108:860-3.
  5. Goodwin WJ. Distant metastases from oropharyngeal cancer. ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63:222-3.
  6. Holsinger FC, Myers JN, Roberts DB, Byers RM: Clinicopathologic predictors of distant metastases from head and neck squamous cell carcinoma. Abstracts from 5th Int Conf on Head Neck Cancer, San Francisco 2000, abstr. 120.
  7. Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977;40:145-51. 
  8. Burn JI. Obstructive lymphopathy. In: Gooneratne BW, ed. Lymphography: clinical and experimental. London, England: Butterworths Publishing, 1974:36-7.
  9. Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14.
  10. Paccagnella A, Morello M, Da-Mosto MC, Baruffi C, Marcon ML, Gava A, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer. 2010;18:837-45.
  11. Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer.Curr Treat Options Oncol. 2012 Mar;13:35-46.
  12. Salama JK, Gillison ML, and Brizel DM . Oropharynx. In: Halperin EC, Wazer DE, Perez CA, Brady LW, editors. Perez and Brady’s Principles and Practice of Radiation Oncology. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 832.

Corresponding Author

Dr Ashutosh Kumar

Department of Radiotherapy, Pt. B.D. Sharma PGIMS, Rohtak, Haryana, India